The University of Birmingham has received the ‘UK Research Paper of the Year’ award for its research paper on the results from BUMPES trial, at The BMJ Awards 2018.

The randomised, controlled BUMPES trial was conducted to investigate the most ideal position for a first-time mother, administered with low dose epidural, to improve the chance of a birth without interventions such as forceps or caesarean.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

“The researchers concluded that adopting a lying down on their side position, instead of being upright, during the later stages of labour provides a higher chance of delivery without medical intervention.”

The trial enrolled 3,093 women across 41 UK hospitals between October 2010 and January 2014. It was funded by the National Institute for Health Research.

Based on the findings, the researchers concluded that adopting a lying down on their side position, instead of being upright, during the later stages of labour provides a higher chance of delivery without medical intervention.

University of Birmingham, Birmingham Clinical Trials Unit director Peter Brocklehurst said: “This study shows there are simple things we can do which can improve outcomes for women and their babies.

“Adopting this practice into routine clinical care for these women will be easy and will mean tens of thousands of women and babies in the UK, and hundreds of thousands of women and babies in the world, will be able to have a straightforward birth without the need for forceps, vacuum or Caesarean section.”

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Another research paper authored by the university on the STAMPEDE trial results was also short-listed for the BMJ Awards 2018.

Funded by the Cancer Research UK, the STAMPEDE trial indicated that addition of abiraterone drug to hormone therapy at the beginning of treatment improves survival in prostate cancer patients by 37%.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Awarded for Innovation in Remote Hearing Diagnostics , hearX’s Self Test Kit (STK) delivers clinically validated audiometry via smart devices, enabling remote, scalable hearing assessments in homes, clinics and retail. Learn how hearX is redefining hearing care delivery and reducing costs for providers globally.

Discover the Impact